7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
      
    		                                             
      operating activities
    		                                             
      net income
    		5,873,000 9,413,000 -1,483,000 1,656,000 1,425,000 -5,862,000 -6,852,000 -2,163,000 -4,036,000 -13,714,000 -24,780,000 -9,285,000 -12,914,000 -13,618,000 -8,855,000 -7,042,000 -6,819,000 -9,221,000 -12,448,000 -3,502,000 -2,558,000 1,353,000 -1,133,000 636,000 782,000 -1,931,000 -1,296,000 -275,000 1,205,000 -377,000 -1,480,000 -838,000 406,000 411,000 -1,482,000 -1,723,000 -1,637,000 -964,000 -2,572,000 -3,001,000 -4,643,000 -4,625,000 -4,936,000 -4,276,000 -8,509,000 
      adjustments to reconcile net income to cash from operating activities:
    		                                             
      depreciation and amortization
    		4,051,000 3,962,000 3,791,000 3,924,000 4,381,000 4,376,000 3,785,000 3,029,000 2,990,000 3,253,000 3,202,000 2,897,000 2,600,000 2,707,000 2,717,000 2,770,000 2,944,000 3,158,000 3,093,000 2,301,000 1,666,000 1,723,000 1,381,000 1,274,000 1,181,000 1,564,000 1,613,000 1,485,000 1,136,000 964,000 927,000 1,024,000 1,095,000 1,077,000 1,036,000 1,229,000 1,093,000 739,000 785,000 742,000 671,000 563,000 566,000 440,000 505,000 
      stock-based compensation expense
    		9,499,000 9,456,000 9,830,000 8,294,000 8,340,000 8,646,000 8,152,000 7,301,000 6,892,000 6,637,000 12,331,000 8,567,000 8,643,000 8,634,000 7,549,000 6,808,000 6,443,000 6,527,000 8,448,000 2,602,000 2,430,000 2,227,000 1,653,000 1,771,000 1,845,000 1,873,000 1,357,000 1,222,000 1,299,000 1,286,000 968,000 855,000 895,000 888,000 781,000 731,000 776,000 743,000 696,000 653,000 749,000 897,000 703,000 890,000 2,001,000 
      realized gain on nonmonetary exchange of preferred stock investment
    		0                                             
      other
    		213,000 602,000 349,000 -1,295,000 -135,000 -116,000 -202,000 2,481,000 -549,000 -188,000 -397,000 1,023,000 102,000 5,000 -79,000 -996,000 -386,000 -315,000 -230,000 35,000 16,000 29,000 73,000 -38,000 46,000 100,000 -3,000 -3,000 -275,000 15,000 23,000 -626,000 187,000 -41,000 97,000 -172,000 179,000 30,000 9,000 2,000 22,000 3,000 -116,000   
      changes in operating assets and liabilities:
    		                                             
      accounts and other receivables
    		-9,912,000 -2,050,000 -15,965,000 15,303,000 -3,794,000 -7,508,000 -10,718,000 10,153,000 -12,409,000 -17,337,000 -15,847,000 -8,034,000 -19,821,000 -15,312,000 -23,815,000 -7,397,000 -17,977,000 -21,991,000 -18,805,000 -5,204,000 -11,966,000 -14,405,000 -11,697,000 -4,190,000 -6,642,000 -6,046,000 -5,894,000 344,000 -3,424,000 -4,242,000 -3,926,000 -55,000 -3,196,000 -3,596,000 -3,372,000  -1,029,000         
      prepaid expenses and other assets
    		44,000 -380,000 -204,000 817,000 101,000 2,010,000 287,000 854,000 452,000 552,000 -3,765,000 -807,000 -1,599,000 -761,000 -2,060,000 -1,133,000 170,000 -761,000 -1,331,000 -860,000 -1,535,000 -249,000 -195,000 -707,000 -714,000 664,000 325,000 -2,079,000 3,519,000 -3,939,000 -129,000 118,000 -114,000 36,000 -219,000  -246,000         
      accounts payable, accrued liabilities, and other liabilities
    		10,027,000 -537,000 1,527,000 2,434,000 1,377,000 3,404,000 -5,131,000 5,476,000 2,632,000 -1,316,000 -5,148,000 2,388,000 45,000 2,509,000 -1,806,000 4,443,000 5,225,000 -907,000 35,000 3,349,000 6,086,000 -806,000 1,322,000 1,304,000 1,363,000 187,000 1,256,000 682,000 1,282,000 1,657,000 910,000 897,000 1,209,000             
      reserve for veterinary invoices
    		1,538,000 -1,710,000 2,407,000 -4,841,000 -3,934,000 -1,650,000 -885,000 1,788,000 5,258,000 7,833,000 4,606,000 4,164,000 3,061,000 -1,785,000 -1,213,000 914,000 2,984,000 5,691,000 1,179,000 -30,000 4,428,000 1,439,000 1,825,000 1,872,000 1,042,000 1,067,000 1,078,000 1,956,000 191,000 550,000 743,000               
      deferred revenue
    		7,904,000 4,052,000 15,712,000 -7,889,000 7,534,000 3,556,000 13,998,000 -11,412,000 10,168,000 10,875,000 22,936,000 106,000 17,584,000 14,491,000 23,972,000 6,789,000 13,640,000 15,632,000 18,324,000 5,273,000 11,239,000 13,539,000 9,695,000 2,610,000 5,841,000 5,444,000 5,523,000 332,000 2,472,000 3,620,000 4,041,000 92,000 2,146,000 2,711,000 4,218,000 319,000 795,000 608,000 676,000 469,000 561,000 420,000 329,000 54,000 520,000 
      net cash from operating activities
    		29,237,000 15,025,000 15,964,000 23,702,000 15,295,000 6,856,000 2,434,000 17,507,000 11,398,000 -3,405,000 -6,862,000 1,019,000 -2,299,000 -3,130,000 -3,590,000 5,156,000 6,224,000 -2,187,000 -1,735,000 3,964,000 9,806,000 4,850,000 2,924,000 4,532,000 4,744,000 2,922,000 3,959,000 3,664,000 7,405,000 -466,000 2,077,000 2,977,000 3,008,000 1,824,000 1,857,000 3,438,000 1,308,000 1,558,000 -1,298,000 -657,000 -872,000 -3,988,000 -4,908,000 -1,101,000 -3,265,000 
      capex
    		-5,027,000 -3,483,000 -1,125,000 -1,808,000 -1,981,000 -3,022,000 -2,371,000 -3,824,000 -4,978,000 -4,650,000 -3,941,000 -5,992,000 -3,217,000 -3,947,000 -2,608,000 192,000 -2,778,000 -3,092,000 -2,130,000 248,000 -933,000 -1,825,000 -1,141,000 271,000 -2,229,000 -406,000 -737,000 -1,139,000 -53,474,000 -1,905,000 -312,000 -1,025,000 -804,000 -802,000 -462,000 -395,000 -456,000 -437,000 -653,000 -1,078,000 -1,172,000 -1,054,000 -1,590,000 -1,620,000 -1,745,000 
      free cash flows
    		24,210,000 11,542,000 14,839,000 21,894,000 13,314,000 3,834,000 63,000 13,683,000 6,420,000 -8,055,000 -10,803,000 -4,973,000 -5,516,000 -7,077,000 -6,198,000 5,348,000 3,446,000 -5,279,000 -3,865,000 4,212,000 8,873,000 3,025,000 1,783,000 4,803,000 2,515,000 2,516,000 3,222,000 2,525,000 -46,069,000 -2,371,000 1,765,000 1,952,000 2,204,000 1,022,000 1,395,000 3,043,000 852,000 1,121,000 -1,951,000 -1,735,000 -2,044,000 -5,042,000 -6,498,000 -2,721,000 -5,010,000 
      investing activities
    		                                             
      purchases of investment securities
    		-41,021,000 -101,125,000 -40,875,000 -26,118,000 -26,126,000 -62,056,000 -19,193,000 -56,547,000 -29,458,000 -45,136,000 -34,795,000 -147,346,000 -78,292,000 -24,476,000 -22,892,000 -33,384,000 -18,915,000 -31,216,000 -12,157,000 -21,314,000 -17,422,000 -14,971,000 -11,579,000 -20,014,000 -13,270,000 -14,872,000 -17,350,000   -13,246,000 -7,140,000 -11,216,000 -5,809,000 -9,723,000 -5,172,000 -15,624,000 -4,769,000 -7,264,000 -3,959,000 -8,718,000 -5,016,000 -7,860,000 -3,206,000   
      maturities and sales of investment securities
    		43,563,000 61,022,000 33,242,000 45,886,000 26,089,000 36,673,000 19,005,000 42,905,000 29,713,000 43,859,000 73,793,000 134,718,000                                  
      purchases of property, equipment, and internal-use software
    		-5,302,000 -2,976,000 -1,928,000 -1,858,000 -1,913,000 -2,880,000 -3,065,000 -3,970,000 -4,391,000 -4,735,000 -5,184,000                                   
      net cash from investing activities
    		-2,321,000 -42,467,000 -8,973,000 18,457,000 -1,460,000 -27,717,000 -2,737,000 -17,447,000 -3,299,000 -5,529,000 33,914,000 -30,552,000 -11,827,000 -10,886,000 -14,251,000 -20,106,000 -13,171,000 -14,034,000 -4,602,000 -58,168,000 -9,701,000 -912,000 -7,966,000 -5,217,000 -9,210,000 -4,079,000 -9,502,000 -16,622,000 -57,201,000 -4,796,000 -2,832,000 -4,623,000 -2,635,000 -1,325,000 -4,473,000 -1,417,000 -2,047,000 -2,098,000 -946,000 -3,305,000 -3,174,000 -2,893,000 -551,000 -4,697,000 -6,972,000 
      financing activities
    		                                             
      repayment of debt financing
    		-188,000 -15,187,000 -338,000    -338,000 -337,000 -338,000 -435,000 -607,000                 0                0  
      proceeds from exercise of stock options
    		80,000 303,000 1,024,000 23,000 258,000 99,000 372,000 1,374,000 628,000 513,000 140,000 706,000 413,000 571,000 600,000 551,000 698,000 1,120,000 1,238,000 1,717,000 2,629,000 1,108,000 559,000 727,000 629,000 965,000 661,000 729,000 1,216,000 1,175,000 481,000 463,000 435,000   1,009,000 951,000 1,299,000 486,000 421,000 113,000 434,000 367,000 50,000 115,000 
      shares withheld to satisfy tax withholding
    		-1,179,000 -773,000 -915,000 -1,129,000 -802,000 -343,000 -245,000 -240,000 -272,000 -171,000 -853,000 -579,000 -850,000 -632,000 -2,298,000 -1,002,000 -979,000 -870,000 -1,881,000 -459,000 -215,000 -120,000 -321,000 -57,000 -1,363,000 -50,000 -197,000 0                  
      net cash from financing activities
    		-1,441,000 -15,887,000 -459,000 -1,674,000 -1,039,000 -958,000 -286,000 569,000 24,840,000 -93,000 33,810,000 14,682,000 -710,000 -5,994,000 52,765,000 -451,000 -281,000 250,000 -643,000 163,573,000 4,892,000 -1,521,000 3,904,000 4,670,000 2,243,000 1,738,000 5,393,000 5,552,000 -11,059,000 70,971,000 5,765,000 2,161,000 17,000 2,008,000 895,000 1,720,000 3,254,000 1,225,000 1,473,000 421,000 -146,000 434,000 -14,917,000 -141,000 60,049,000 
      effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
    		-1,037,000 1,790,000 -52,000 -1,896,000 482,000 -150,000 -313,000 1,254,000 -906,000 -184,000 260,000 505,000 -1,268,000 -835,000 139,000 305,000 -461,000 178,000 230,000 198,000 220,000 375,000 -809,000 156,000 -129,000 176,000 220,000 -719,000 108,000 -271,000 70,000 -58,000 255,000             
      net change in cash, cash equivalents, and restricted cash
    		24,438,000 -41,539,000 6,480,000 38,589,000 13,278,000 -21,969,000 -902,000 1,883,000 32,033,000 -9,211,000 61,122,000 -14,346,000 -16,104,000 -20,845,000 35,063,000 -15,096,000 -7,689,000 -15,793,000 -6,750,000 109,567,000 5,217,000 2,792,000 -1,947,000 4,141,000 -2,352,000 757,000 70,000 -8,125,000 -60,747,000 65,438,000 5,080,000    -1,700,000           
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 199,530,000 0 0 0 170,464,000 0 0 0 84,637,000 0 0 0 100,869,000 0 0 0 146,197,000 0 0 0 30,568,000 0 0 0 27,952,000 0 0 0 26,306,000 0 0 0 24,237,000           
      cash, cash equivalents, and restricted cash at end of period
    		24,438,000 -41,539,000 206,010,000 38,659,000 13,278,000 -21,969,000 169,562,000 1,883,000 32,033,000 -9,211,000 145,759,000 -14,346,000 -16,104,000 -20,845,000 135,932,000 -15,096,000 -7,689,000 -15,793,000 139,447,000 109,567,000 5,217,000 2,792,000 28,621,000 4,141,000 -2,352,000 757,000 28,022,000 -8,125,000 -60,747,000 65,438,000 31,386,000 457,000 645,000 2,667,000 22,537,000           
      supplemental disclosures
    		                                             
      noncash investing and financing activities:
    		                                             
      purchases of property, equipment, and internal-use software included in accounts payable and accrued liabilities
    		275,000 -507,000 803,000 50,000 -68,000 -142,000 694,000 146,000 -587,000 85,000 1,243,000                                   
      purchase of intellectual property in exchange for preferred stock investment
    		0                                             
      goodwill impairment charges
    		                                             
      cash paid in business acquisition, net of cash acquired
    		                                             
      proceeds from debt financing, net of financing fees
    		       0 24,972,000 0 35,130,000 14,826,000 -119,000 -32,000 54,463,000        3,744,000 4,000,000 3,000,000 967,000 5,200,000 4,242,000 -61,000 3,750,000 5,500,000 1,980,000 961,000             
      repurchases of common stock
    		            -4,000                                 
      income taxes paid
    		                                   7,000 8,000   -256,000 0 215,000 -98,000 -18,000 0 
      interest paid
    		                                   61,000 64,000 44,000 -16,000 -310,000 -104,000 508,000 -249,000 -2,866,000 915,000 
      repayments of debt financing
    		    -338,000                                         
      cash paid in business acquisitions, net of cash acquired
    		                                             
      purchases of property and equipment
    		           -5,478,000 -4,131,000 -3,926,000 -3,553,000             -1,080,000 -53,486,000 -1,378,000 -992,000 -884,000 -983,000 -802,000 -462,000 -395,000 -456,000 -437,000 -653,000 -1,078,000 -1,172,000 -1,054,000 -1,590,000 -1,620,000 -1,745,000 
      issuance of common stock, net of offering costs
    		                                             
      repurchase of common stock
    		                                             
      purchases of property and equipment included in accounts payable and accrued liabilities
    		           -514,000 914,000 -21,000 945,000 192,000 -11,000 -205,000 753,000 248,000 340,000 -82,000 355,000 271,000 -423,000 496,000 141,000 -59,000 12,000 -527,000 680,000 -141,000 179,000             
      acquisition-related contingent consideration recorded as a liability
    		                                             
      repayments of debt
    		            -150,000                                 
      maturities of investment securities
    		             19,013,000 12,199,000 18,803,000 8,486,000 20,102,000 10,478,000 14,249,000 9,013,000 15,704,000 5,100,000 21,538,000 6,329,000 11,690,000 10,205,000   9,715,000 5,300,000 7,494,000 4,166,000 7,841,000 3,871,000 14,670,000 3,239,000 5,638,000 3,700,000 6,600,000 3,314,000 6,021,000 4,245,000   
      purchases of other investments
    		                           0                  
      issuance of common stock for cashless exercise of warrants
    		                       0 0 0 4,500,000 0 0 0 3,000,000               
      purchases of property, equipment and intangible assets
    		                -2,767,000 -2,887,000 -2,883,000  -1,273,000 -1,743,000 -1,496,000  -1,806,000 -902,000 -878,000                   
      borrowings from line of credit, net of financing fees
    		                    2,478,000                         
      repayments to line of credit
    		                    0                         
      acquisition of lease intangibles, related to corporate real estate acquisition
    		                           0                  
      other financing
    		                       0 -23,000 -144,000 -271,000 900,000 -179,000 -140,000 -216,000               
      issuance of common stock for acquisition of corporate real estate
    		                           0                  
      gain on sale of equity method investment
    		                               0 0             
      proceeds from sale of equity method investment
    		                               0 0             
      proceeds from public offering of common stock, net of offering costs
    		                           -19,000 -196,000                 
      property and equipment acquired under financing leases
    		                                             
      proceeds from exercise of warrants
    		                            0                 
      property and equipment acquired under capital lease
    		                               0 623,000             
      purchases of fixed maturity investment securities
    		                                             
      maturities of fixed maturity investment securities
    		                                             
      property and equipment acquired under lease
    		                                             
      other investments
    		                               -17,000 -9,000 -43,000 -2,710,000           
      taxes paid related to net share settlement of equity awards
    		                                             
      cashless exercise of common stock warrants
    		                                             
      claims reserve
    		                                380,000 166,000 1,093,000 1,183,000 799,000 723,000 521,000 114,000 413,000 638,000 76,000 -304,000 1,018,000 
      payments on financing obligations
    		                                             
      net increase in cash, cash equivalents, and restricted cash
    		                                645,000             
      payments on capital lease obligation
    		                                             
      accounts payable
    		                                  64,000 683,000 429,000 -260,000 -200,000 -18,000 223,000 -165,000 -387,000 298,000 76,000 
      accrued liabilities
    		                                  -598,000 875,000 450,000 117,000 -1,267,000 -2,000 670,000 119,000 -736,000 949,000 30,000 
      other payables
    		                                  239,000 231,000 -301,000 272,000 135,000 229,000 526,000 -612,000 -330,000 58,000 -576,000 
      proceeds from stock option exercises
    		                                  1,037,000           
      (repayment of) proceeds from debt financing and debt financing fees
    		                                  -40,000           
      payments on capital lease obligations
    		                                  -102,000 -94,000          
      effect of foreign exchange rates on cash
    		                                  21,000 -130,000 -96,000 -4,000 341,000 -191,000 -277,000 110,000 -228,000 -32,000 -31,000 
      increase in payables for property and equipment
    		                                  93,000 23,000 6,000 17,000 58,000 -212,000 -39,000 716,000 -367,000 423,000 -30,000 
      property and equipment acquired under capital leases
    		                                  45,000  289,000         
      amortization of debt discount and prepaid loan fees
    		                                       16,000      
      warrant income
    		                                           0  
      accounts and other receivable
    		                                             
      prepaid expenses and other current assets
    		                                      153,000 -37,000 -488,000 -228,000 -152,000 87,000 -335,000 
      equity method investment
    		                                       0      
      tax withholding on restricted stock
    		                                   0    0 -259,000 0 -384,000   
      proceeds from (repayment of) debt financing
    		                                   1,000,000 3,002,000 -1,000 987,000       
      other financing costs
    		                                             
      net proceeds from ipo
    		                                             
      warrants issued in conjunction with debt issuance
    		                                           1,000  
      cashless exercise of preferred stock warrants
    		                                           0 271,000 
      common stock warrant reclassification to equity
    		                                             
      net change in cash and cash equivalents
    		                                    2,419,000 681,000 -430,000 -3,732,000 -4,469,000 -6,337,000 -20,604,000 -5,971,000  
      cash and cash equivalents at beginning of period
    		                                    0 0 17,956,000 0 0 0 53,098,000 0 0 
      cash and cash equivalents at end of period
    		                                    2,419,000 681,000 17,526,000 -3,732,000 -4,469,000 -6,337,000 32,494,000 -5,971,000 49,781,000 
      payments of capital lease obligations
    		                                             
      accounts receivables
    		                                      -234,000       
      accounts receivable
    		                                         -998,000 75,000 702,000 -508,000 
      restricted cash
    		                                           0 2,700,000 
      exchange of stock for equity method investment
    		                                             
      release of restricted cash
    		                                             
      repayment of debt financing and loan fees
    		                                             
      proceeds from line of credit
    		                                             
      net proceeds from initial public offering
    		                                             
      increase in payables for deferred financing costs
    		                                            -1,351,000 
      warrant expense
    		                                             
      advance on term loan
    		                                             
      deferred financing costs
    		                                             
      payment on line of credit
    		                                         0 -14,900,000   
      settlement of forward contract
    		                                             
      issuance of preferred stock
    		                                             
      purchase of treasury stock
    		                                             
      redemption of preferred stock
    		                                             
      proceeds from line of credit and debt financing
    		                                           0  
      amortization of prepaid loan fee
    		                                             
      amortization of debt discount
    		                                            4,455,000 
      loss on disposal of equipment
    		                                            0 
      income from equity method investment
    		                                             
      net amortization on bonds
    		                                            4,000 
      purchases of investment securities, held-to-maturity
    		                                            -10,189,000 
      maturities of investment securities, held-to-maturity
    		                                            4,962,000 
      payment of loan fee
    		                                             
      (repayments of) proceeds from line of credit
    		                                             
      net increase in cash and cash equivalents
    		                                             
      exchange of stock and intangible asset for equity method investment
    		                                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.